SARS-CoV2 Breakthrough Infections in Elderly Third Booster and Vaccinated Population Considered Vaccine Immune During Omicron (B.1.1.529)Variant Surge in Israel

Authors

  • Venkata R Emani Central Valley Cardiovascular Associates, Inc, USA
  • Dheeraj Nandanoor Stockton Primary Care, USA
  • Raghunath Reddy Stockton Primary Care, USA
  • Abirath S Nakka Stockton Primary Care, USA
  • Kartik K Goswami San Joaquin Critical Care Medical Group, USA
  • Shaila R Emani Central Valley Cardiovascular Associates, Inc, USA
  • Nikhila K Reddy Stockton Primary Care, USA
  • Kailash R Maddula Central Valley Cardiovascular Associates, Inc, USA
  • Nidhi K Reddy Stockton Primary Care, USA
  • Sanjeev Goswami San Joaquin Critical Care Medical Group, USA

DOI:

https://doi.org/10.5530/ctbp.2022.2.22

Keywords:

Nil

Abstract

The fourth booster vaccination was approved in Israel during Omicron (B.1.1.529) variant surge due to increasing SARS-CoV2 breakthrough infections among recently vacci-nated, reasons for this resurgence is not clear.

In this Observational study, we analyzed verified SARS-CoV2 infections among over 60 years of age based on vaccination schedule (December 20, 2020-January 29, 2022); infec-tions, severe illness and deaths based on vac-cine immunity (between August 1, 2021-Janu-ary 29, 2022) using Israel COVID-19 dashboard data. Read more...

SARS-CoV2 Breakthrough Infections in Elderly Third Booster and Vaccinated Population Considered Vaccine Immune During Omicron (B.1.1.529)Variant Surge in Israel

Downloads

Published

20-05-2022

How to Cite

Emani, V. R. ., Nandanoor, D. ., Reddy, R. ., Nakka, A. S., Goswami, K. K., Emani, S. R., Reddy, N. K., Maddula, K. R., Reddy, N. K., & Goswami, S. . (2022). SARS-CoV2 Breakthrough Infections in Elderly Third Booster and Vaccinated Population Considered Vaccine Immune During Omicron (B.1.1.529)Variant Surge in Israel. Current Trends in Biotechnology and Pharmacy, 16(2), 235–252. https://doi.org/10.5530/ctbp.2022.2.22

Issue

Vol. 16 No. 2 (2022): Current Trends in Biotechnology and Pharmacy

Section

Research Paper